All In MedTech

FDA Clearance Tracker · P100018-S004

PIPELINE EMBOLIZATION DEVICE

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 22, 2012 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 22, 2012

Approved

Time to decision

185 days

Received Sep 19, 2011. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P100018-S004
Device name
PIPELINE EMBOLIZATION DEVICE
Applicant location
Irvine, CA
Received
Sep 19, 2011
Decided
Mar 22, 2012
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P100018

Device type

Device class
Class III

Every decision under product code OUT

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A MANUFACTURING SITE LOCATED AT EV3 NEUROVASCULAR, IRVINE, CALIFORNIA AS AN ADDITIONAL MANUFACTURING SITE FOR THE DEVICE.

Source documents

Other decisions for Micro Therapeutics, Inc. d/b/a ev3 Neurovascular

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.